Mizuho lowered the firm’s price target on Select Medical (SEM) to $17 from $18 and keeps an Outperform rating on the shares. The firm reduced estimates post the company’s Q3 report.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEM: